By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Generex Biotechnology Corporation (GNBT) Announces Elimination Of Outstanding Derivative Securities 2/15/2017 8:02:48 AM
Generex Biotechnology Corporation (GNBT) Provides Update On Deal To Acquire Controlling Equity Interest In Emmaus Life Sciences 2/9/2017 7:51:55 AM
Generex Biotechnology Corporation (GNBT) Welcomes Dr. Yutaka Niihara, M.D., M.P.H. To Its Board Of Directors 1/26/2017 10:59:12 AM
Emmaus Life Sciences Release: Yutaka Niihara, MD, MPH, CEO Of Pharma, Appointed Executive Chairman Of Generex Biotechnology Corporation (GNBT) 1/25/2017 10:01:06 AM
Generex Biotechnology Corporation (GNBT) Release: Company Welcomes Dr. Yutaka Niihara, M.D., M.P.H. To Its Board Of Directors 1/25/2017 7:45:46 AM
Generex Biotechnology Corporation (GNBT) Release: Company Announces Closing Of Acquisition Of Controlling Equity Interest In Hema Diagnostic Systems 1/23/2017 10:56:45 AM
Generex Biotechnology Corporation (GNBT) Release: Company Announces Deal To Acquire Controlling Equity Interest In Emmaus Life Sciences 1/23/2017 10:55:20 AM
Generex Biotechnology Corporation (GNBT) Announces Memorandum Of Understanding In Respect Of A Phase II Clinical Trial For The Antigen Express Prostate Cancer Vaccine 10/15/2015 9:51:19 AM
Generex Biotechnology Corporation (GNBT) Announces Agreement To Acquire Equity Interest In MediTemp Ltd. 10/13/2015 7:42:24 AM
Generex Biotechnology Corporation (GNBT) Announces Agreement To Acquire Equity Interest In Alfa Rhythm Ltd. 10/6/2015 8:34:02 AM
12345678910...
//-->